Q&A With David Shavelle, MD, From the University of Southern California: Updating the Guidelines for Acute Coronary Syndromes

Video

As new medications and agents are developed organizations like the American College of Cardiology and the American Heart Association update their guidelines on treating a variety of conditions. Recently work was completed to help doctors treating acute coronary syndromes.

As new medications and agents are developed organizations like the American College of Cardiology and the American Heart Association update their guidelines on treating a variety of conditions. Recently work was completed to help doctors treating acute coronary syndromes.

David Shavelle, MD, from the University of Southern California discussed what the new guidelines mean for treatment and also some new medications that doctors can prescribe their patients during the American College of Physicians Internal Medicine meeting in Boston. Shavelle said in some cases the new medications could be used instead of the more commonly used and popular clopidogrel even as further studies are conducted.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.